Copy
View email in your browser

SWI Adds Invitae (NVTA:NYSE) to its Portfolio
The "Amazon" of Genetic Testing

Los Angeles, April 7, 2016 - StockWatchIndex announced today that it has added INVITAE Corporation (NVTA:NYSE) to its SWI Portfolio. We agree with the Company's CEO that there is a need to bring genetic testing costs down to a reasonable level for the benefit of a broad range of patients. We believe that INVITAE is well ahead of the competition and on a path to its goal to become the "Amazon" of genetic testing. Accordingly, we consider this another great find for our SWI portfolio.

INVITAE Corporation is a genetic information company that focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare. It processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas.

INVITAE Corporation also offers solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Canada, Israel, and internationally. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.

                       
Download INVITAE

Fact Sheet Here 
                 

Please visit our sites www.stockwatchindex.com and  www.swiresearch.com. We would appreciate if you could
pass our newsletter on to your friends and colleagues. We always appreciate your feedback and comments.

If you are interested in a research report for your public company, please contact us at info@swiresearch.com.

                                         

Rainer Poertner - Chief Analyst    

StockWatchIndex  and SWI Research (SWI) are not registered investment advisers and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has  been not been compensated for the  publication of the information herein. The included information is subject to change without notice. Please visit www.swiresearch.com/#!legal-ease/lmvw1  for a full text of our Disclaimer, Privacy policy and Terms of Use.
Copyright © 2016 DynamicMarketConcepts, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp